fda warning about compounded semaglutide The has received reports of adverse events after patients used versions of semaglutide. Some compounders may also be using unapproved salt forms., Patients should avoid compounded Compounded "semaglutide" is not FDA-approved
Description
After propensity scores overlap weighting, 13,965 pairs of GLP1-RA versus DPP4i initiators (cohort entry: 20062022
| 12 comments on LinkedIn

When compounded semaglutide and tirzepatide fail sterility and potency testing, and get distributed anyway, the implications extend far beyond one pharmacy.

In late-stage type 2 diabetes mellitus (T2DM), impaired islet cell function leads to absolute insulin deficiency, thereby disrupting blood glucose homeostasis

Among the major complications are cardiovascular disease, kidney disease, diabetic foot ulcers, diabetic retinopathy, and neurological disorders
